Showing results (151-160 of 2,881) with videos related to
Sort By:
Pageof 289
Current Opinion in Cardiology|July 17, 2014
Which drug should we use for stroke prevention in atrial fibrillation?Yee C Lau, Gregory Y H LipTrends in Cardiovascular Medicine|December 3, 2014
Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?Mikhail S Dzeshka, Gregory Y H LipEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|December 31, 2020
Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisalDeirdre A Lane, Gregory Y H LipAnnals of Internal Medicine|December 6, 2021
In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategiesAmeenathul M Fawzy, Gregory Y H LipExpert Opinion on Pharmacotherapy|January 29, 2010
Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trialChee W Khoo, Gregory Y H LipExpert Opinion on Pharmacotherapy|November 13, 2015
Edoxaban for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillationMikhail S Dzeshka, Gregory Y H LipArrhythmia & Electrophysiology Review|February 3, 2016
Monitoring the Effects and Antidotes of the Non-vitamin K Oral AnticoagulantsNur A Rahmat, Gregory Y H LipPlos Medicine|June 1, 2021
Hypertension and atrial fibrillation: Closing a virtuous circleYing X Gue, Gregory Y H LipCritical Pathways in Cardiology|February 16, 2022
The Patient Pathway Review for Atrial FibrillationChun Shing Kwok, Gregory Y H LipEuropean Heart Journal. Quality of Care & Clinical Outcomes|September 12, 2023
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040Elizabeth M Camacho, Gregory Y H LipPageof 289